Why HCA Healthcare, Inc. (HCA) stock moved
HCA Healthcare, Inc. (HCA) shares fell 3.3% to $449.96 as of October 28, 2026, a moderate decline from the prior close of $465.26. BestStocks flagged the session as a major change for HCA. The move is tied to price move down. Below, we break down what changed for HCA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HCA fell 3.3% to $449.96
HCA fell 3.3% in its latest session, moving from $465.26 to $449.96.
What it means for HCA Healthcare, Inc. investors
For HCA Healthcare, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: HCA Healthcare rallied 6.05% to $413.18 following upbeat second-quarter earnings reported on July 27, according to Benzinga; Positive price momentum. Weighing against that: Material negative event; Negative session, down 3.3%. Wall Street's consensus price target sits at $456.81, implying +1.5% upside from $449.96. BestStocks rates the overall signal quality low (58/100). With earnings roughly 90 days out, the next report is the most likely near-term test of the move.
HCA price reaction
HCA last traded at $449.96, down $15.30 (-3.29%) from the previous close of $465.26. The session traded on 2.0× average volume (very high), so the move carried above-average conviction. Over the past month the stock has ranged between $423.39 and $470.44, and it currently sits about 56% of the way up that band.
Bullish and bearish analyst opinions on HCA Healthcare, Inc. (HCA)
The consensus analyst price target on HCA Healthcare, Inc. (HCA) is $456.81, 1.5% above the recent $449.96. Over the past 90 days analysts logged 0 upgrades, 6 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HCA line up.
The bullish case
- Wall Street's consensus price target of $456.81 implies +1.5% upside from $449.96.
- The Street's most bullish target is $579.00 (+28.7%).
- HCA Healthcare rallied 6.05% to $413.18 following upbeat second-quarter earnings reported on July 27, according to Benzinga.
- Positive price momentum.
The bearish case
- The most bearish analyst target is $369.00 (-18.0%).
- Material negative event.
- Negative session, down 3.3%.
- High volume 2.0x on decline — distribution signal.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 28, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HCA
In-depth HCA event analyses
Frequently asked questions about HCA
Why did HCA Healthcare, Inc. (HCA) stock move?
HCA fell 3.3% to $449.96. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did HCA stock fall?
HCA lost 3.29% ($15.30) versus the prior close of $465.26, last trading at $449.96 on 2.0× average volume.
When is HCA Healthcare, Inc.'s next earnings date?
HCA's next earnings report is estimated for 2027-01-26 — about 90 days away.
What is the analyst price target for HCA?
The consensus analyst price target for HCA is $456.81, about 1.5% above the current $449.96. Over the past 90 days, analysts recorded 0 upgrades, 6 maintains, and 0 downgrades.
How BestStocks tracks HCA
This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for HCA, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 28, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.